Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-02

FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for rabeprazole sodium submitted by Torrent Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rabeprazole sodium (rabeprazole)

Snippet

SUPPL AP for RABEPRAZOLE SODIUM (RABEPRAZOLE SODIUM)